Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Combination Chemotherapy and Alemtuzumab in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

ClinicalTrials.gov ID: NCT00262925

Public ClinicalTrials.gov record NCT00262925. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 5:09 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Study of MOAD (Methotrexate, Vincristine, L-asparaginase and Dexamethasone) With Subcutaneous Campath for Adults With Relapsed or Refractory Acute Leukemia (ALL)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This phase II trial is studying how well giving combination chemotherapy together with alemtuzumab works in treating patients with relapsed or refractory acute lymphoblastic leukemia. Drugs used in chemotherapy work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more cancer cells. Monoclonal antibodies, such as alemtuzumab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread. Others find cancer cells and help kill them or carry cancer-killing substances to them. Giving combination chemotherapy together with alemtuzumab may kill more cancer cells.

Study identification

NCT ID
NCT00262925
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Enrollment
12 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2006 (Type not available)
Primary completion
Oct 2012 (Actual)
Completion
Feb 2013 (Actual)
Last update posted
May 5, 2015

2006 – 2013

United States locations

U.S. sites
58
U.S. states
9
U.S. cities
46
Facility City State ZIP Site status
Rush - Copley Medical Center Aurora Illinois 60504 —
Mercy Hospital and Medical Center Chicago Illinois 60616 —
Joliet Oncology-Hematology Associates Limited Joliet Illinois 60435 —
Edward H Kaplan MD and Associates Skokie Illinois 60076 —
Carle Clinic-Urbana Main Urbana Illinois 61801 —
Saint Anthony Memorial Health Center Michigan City Indiana 46360 —
Siouxland Hematology Oncology Associates Sioux City Iowa 51101 —
Mercy Medical Center-Sioux City Sioux City Iowa 51104 —
Saint Luke's Regional Medical Center Sioux City Iowa 51104 —
Cancer Center of Kansas - Chanute Chanute Kansas 66720 —
Cancer Center of Kansas - Dodge City Dodge City Kansas 67801 —
Cancer Center of Kansas - El Dorado El Dorado Kansas 67042 —
Cancer Center of Kansas - Fort Scott Fort Scott Kansas 66701 —
Cancer Center of Kansas-Independence Independence Kansas 67301 —
Cancer Center of Kansas-Kingman Kingman Kansas 67068 —
Lawrence Memorial Hospital Lawrence Kansas 66044 —
Cancer Center of Kansas-Liberal Liberal Kansas 67901 —
Cancer Center of Kansas - Newton Newton Kansas 67114 —
Cancer Center of Kansas - Parsons Parsons Kansas 67357 —
Cancer Center of Kansas - Pratt Pratt Kansas 67124 —
Cancer Center of Kansas - Salina Salina Kansas 67401 —
Cancer Center of Kansas - Wellington Wellington Kansas 67152 —
Associates In Womens Health Wichita Kansas 67208 —
Cancer Center of Kansas-Wichita Medical Arts Tower Wichita Kansas 67208 —
Cancer Center of Kansas - Main Office Wichita Kansas 67214 —
Via Christi Regional Medical Center Wichita Kansas 67214 —
Wesley Medical Center Wichita Kansas 67214 —
Wichita CCOP Wichita Kansas 67214 —
Cancer Center of Kansas - Winfield Winfield Kansas 67156 —
Fairview Ridges Hospital Burnsville Minnesota 55337 —
Mercy Hospital Coon Rapids Minnesota 55433 —
Fairview-Southdale Hospital Edina Minnesota 55435 —
Unity Hospital Fridley Minnesota 55432 —
Hutchinson Area Health Care Hutchinson Minnesota 55350 —
Minnesota Oncology Hematology PA-Maplewood Maplewood Minnesota 55109 —
Saint John's Hospital - Healtheast Maplewood Minnesota 55109 —
Abbott-Northwestern Hospital Minneapolis Minnesota 55407 —
Hennepin County Medical Center Minneapolis Minnesota 55415 —
North Memorial Medical Health Center Robbinsdale Minnesota 55422 —
Metro-Minnesota CCOP Saint Louis Park Minnesota 55416 —
Park Nicollet Clinic - Saint Louis Park Saint Louis Park Minnesota 55416 —
Regions Hospital Saint Paul Minnesota 55101 —
United Hospital Saint Paul Minnesota 55102 —
Saint Francis Regional Medical Center Shakopee Minnesota 55379 —
Lakeview Hospital Stillwater Minnesota 55082 —
Ridgeview Medical Center Waconia Minnesota 55387 —
Rice Memorial Hospital Willmar Minnesota 56201 —
Minnesota Oncology and Hematology PA-Woodbury Woodbury Minnesota 55125 —
Montefiore Medical Center The Bronx New York 10467-2490 —
Case Western Reserve University Cleveland Ohio 44106 —
Geisinger Medical Center Danville Pennsylvania 17822-2001 —
Geisinger Medical Center-Cancer Center Hazelton Hazleton Pennsylvania 18201 —
Penn State Milton S Hershey Medical Center Hershey Pennsylvania 17033-0850 —
Lewistown Hospital Lewistown Pennsylvania 17044 —
Geisinger Medical Group State College Pennsylvania 16801 —
Mount Nittany Medical Center State College Pennsylvania 16803 —
Geisinger Wyoming Valley Wilkes-Barre Pennsylvania 18711 —
University of Wisconsin Hospital and Clinics Madison Wisconsin 53792 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00262925, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 5, 2015 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00262925 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →